12:00 AM
 | 
Sep 24, 2012
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Progenra preclinical data

In mouse models of MM, P5091 significantly reduced tumor volume and increased survival vs. vehicle-treated controls (p<0.001 for both). Additionally, P5091 inhibited growth of MM tumor cells that...

Read the full 119 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >